Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 2 |
2020 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
PDXliver: a database of liver cancer patient derived xenograft mouse models.
BMC Cancer. 2018 May 9;18(1):550. doi: 10.1186/s12885-018-4459-6.
BMC Cancer. 2018.
PMID: 29743053
Free PMC article.
NAD(P)HX epimerase downregulation promotes tumor progression through ROS/HIF-1α signaling in hepatocellular carcinoma.
Sun B, Yu L, Xu C, Li YM, Zhao YR, Cao MM, Yang LY.
Sun B, et al.
Cancer Sci. 2021 Jul;112(7):2753-2769. doi: 10.1111/cas.14925. Epub 2021 May 4.
Cancer Sci. 2021.
PMID: 33932069
Free PMC article.
Item in Clipboard
Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling.
Wang JL, Yang MY, Xiao S, Sun B, Li YM, Yang LY.
Wang JL, et al.
J Exp Clin Cancer Res. 2018 Mar 5;37(1):45. doi: 10.1186/s13046-018-0720-8.
J Exp Clin Cancer Res. 2018.
PMID: 29506567
Free PMC article.
Item in Clipboard
A standardized pathological proposal for evaluating microvascular invasion of hepatocellular carcinoma: a multicenter study by LCPGC.
Sheng X, Ji Y, Ren GP, Lu CL, Yun JP, Chen LH, Meng B, Qu LJ, Duan GJ, Sun Q, Ye XQ, Li SS, Yang J, Liao B, Wang ZB, Zhou JH, Sun Y, Qiu XS, Wang L, Li ZS, Chen J, Xia CY, He S, Li CY, Xu EW, Geng JS, Pan C, Kuang D, Qin R, Guan HW, Wang ZD, Li LX, Zhang X, Wang H, Zhao Q, Wei B, Zhang WJ, Ling SP, Du X, Cong WM; Liver Cancer Pathology Group of China (LCPGC).
Sheng X, et al.
Hepatol Int. 2020 Dec;14(6):1034-1047. doi: 10.1007/s12072-020-10111-4. Epub 2020 Dec 28.
Hepatol Int. 2020.
PMID: 33369707
BACKGROUND AND AIMS: Microvascular invasion (MVI) is a key pathological factor that severely affects the postoperative prognosis of patients with hepatocellular carcinoma (HCC). ...
BACKGROUND AND AIMS: Microvascular invasion (MVI) is a key pathological factor that severely affects the postoperative prognosis of p …
Item in Clipboard
Cite
Cite